Fundraising Fox

Keros Therapeutics

NASDAQ: KROS

Lexington, US · Founded 2015 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

JS
Jasbir S. SeehraExecutive Officer, Director
JK
Julius KnowlesDirector
AL
Alon LazarusDirector
OH
Ohad HammerDirector
RN
Ran NussbaumDirector

Investors · 3

Arkin CapitalHerzliya
Foresite CapitalLarkspur
OrbiMedreportedNew York · $1M – $75Mvia Carl Gordon · board

Reported raises · per SEC filings

Form D private placements
▶$56MraisedMar 2020 · 20 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith RegnanteExecutive Officer
  • Jenn LacheyExecutive Officer
  • Claudia OrdonezExecutive Officer
  • Jasbir SeehraExecutive Officer, Director
  • Nima FarzanDirector
  • Alon LazarusDirector
  • Ran NussbaumDirector
  • Zafrira AvnurDirector
  • Carl GordonDirector
  • Julius KnowlesDirector
Offering amount
$56M
Amount sold
$56M
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.5MraisedNov 2018 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alon LazarusDirector
  • Ran NussbaumDirector
  • Julius KnowlesDirector
  • Zafrira AvnurDirector
  • Jasbir S. SeehraExecutive Officer, Director
  • Ohad HammerDirector
Offering amount
$23M
Amount sold
$11.5M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11MraisedNov 2017 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jasbir S. SeehraExecutive Officer, Director
  • Julius KnowlesDirector
  • Alon LazarusDirector
  • Ohad HammerDirector
  • Ran NussbaumDirector
Offering amount
$11M
Amount sold
$11M
First sale
Apr 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.